Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-5565 (Mirogabalin) in Diabetic Peripheral Neuropathy Pain
NCT01504412Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of mirogabalin in diabetic peripheral neuropathy (DPN), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2012; status: completed.
02
Drugs
mirogabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01504412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01504412.